Novo Nordisk Investigational Site

Minneapolis, Minnesota 55404

We've found

3 trials

at this facility

A Study of the Impact of Hemophilia and Its Treatment on Brain Development, Thinking and Behaviour in Children With Hemophilia

Status: Enrolling, Phase
Updated: 12/31/1969

from

Minneapolis, MN

Use of rFXIII in Treatment of Congenital FXIII Deficiency, a Prospective Multi-centre Observational Study

Status: Enrolling, Phase
Updated: 12/31/1969

from

Minneapolis, MN

A Research Study Looking at How a Factor VIII Medicine Called Turoctocog Alfa Pegol (N8-GP) Works in People With Haemophilia A

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Minneapolis, MN

Use our guide to learn which trials are right for you!